Pfizer Inc (PFE)

PFE on New York Consolidated

34.23USD
28 Apr 2015
Change (% chg)

$-0.36 (-1.04%)
Prev Close
$34.59
Open
$34.74
Day's High
$34.88
Day's Low
$34.22
Volume
28,046,172
Avg. Vol
29,183,103
52-wk High
$35.53
52-wk Low
$27.51

PFE

Chart for PFE

About

Pfizer Inc. is a bio pharmaceutical company. The company applies science and resources to discover, develop and manufacture healthcare products. The Company provides medicines, vaccines and consumer healthcare products. The Company operates its business through three operating segments, which include Global Innovative Pharmaceut... (more)

Overall

Beta: 0.79
Market Cap(Mil.): $212,394.09
Shares Outstanding(Mil.): 6,140.33
Dividend: 0.28
Yield (%): 3.24

Financials

  PFE Industry Sector
P/E (TTM): 24.40 40.17 40.89
EPS (TTM): 1.42 -- --
ROI: 6.17 16.80 16.14
ROE: 12.32 17.30 16.96
Search Stocks

Pfizer cuts full-year forecast on stronger dollar

- U.S. drugmaker Pfizer Inc cut its full-year revenue and profit forecast, blaming a stronger dollar.

8:00am EDT

UPDATE 1-Pfizer cuts full-year forecast on stronger dollar

April 28 - U.S. drugmaker Pfizer Inc cut its full-year revenue and profit forecast, blaming a stronger dollar.

7:55am EDT

Pfizer quarterly revenue falls on stronger dollar

April 28 - Pfizer Inc reported a 4 percent fall in quarterly revenue, hurt by a stronger dollar.

7:09am EDT

BRIEF-AstraZeneca open to acquisitions, smaller deals more likely

* CEO says no comment on Pfizer, completely focused on developing pipeline

24 Apr 2015

DIARY-U.S. MEETINGS/WEEK AHEAD

Thomson Reuters April 23, 2015 - Corporate Meetings for US companies for Week ahead. S&P 500 Earnings - MONTH AHEAD Dividends Non S&P 500 - Weekly Federal Reserve events ConferenceCall/Webcast - Weekly Meetings - Weekly Xtra users can see more details on conference calls & webcasts by hovering your mouse over the RIC, right click, no click on Related Co Data, now click on Co Events.

23 Apr 2015

DIARY-U.S. MEETINGS/WEEK AHEAD

Thomson Reuters April 21, 2015 - Corporate Meetings for US companies for Week ahead. S&P 500 Earnings - MONTH AHEAD Dividends Non S&P 500 - Weekly Federal Reserve events ConferenceCall/Webcast - Weekly Meetings - Weekly Xtra users can see more details on conference calls & webcasts by hovering your mouse over the RIC, right click, no click on Related Co Data, now click on Co Events.

21 Apr 2015

Pfizer wins first U.S. trial over Zoloft birth-defect risk

- Pfizer Inc scored a key victory Friday when it was cleared of liability in the first U.S. trial involving claims that its antidepressant Zoloft can cause birth defects in children born to women who take the drug while pregnant.

17 Apr 2015

Pfizer wins first U.S. trial over Zoloft birth-defect risk

- Pfizer Inc scored a key victory Friday when it was cleared of liability in the first U.S. trial involving claims that its antidepressant Zoloft can cause birth defects in children born to women who take the drug while pregnant.

17 Apr 2015

UPDATE 2-Pfizer wins first U.S. trial over Zoloft birth-defect risk

April 17 - Pfizer Inc scored a key victory Friday when it was cleared of liability in the first U.S. trial involving claims that its antidepressant Zoloft can cause birth defects in children born to women who take the drug while pregnant.

17 Apr 2015

Bristol's Opdivo proves effective against second type of lung cancer

- A large study of Bristol-Myers Squibb Co's Opdivo treatment has been halted after proving the drug is effective against the most common form of lung cancer, the company said, positioning the medicine for far wider use than its already approved lung cancer and melanoma indications.

17 Apr 2015

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $100.82 +0.24
Novartis AG (NOVN.VX) CHF99.55 -0.85
Merck & Co., Inc. (MRK.N) $60.21 +3.11
Roche Holding Ltd. (ROG.VX) CHF273.30 -5.50
Abbott Laboratories (ABT.N) $47.67 +0.18
Bayer AG (BAYGn.DE) €134.40 -3.95
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €94.15 -3.18
AstraZeneca plc (AZN.L) 4,548.00p -157.50
GlaxoSmithKline plc (GSK.L) 1,538.00p -24.00

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks